These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 9334462)

  • 21. Role of oxidized LDL and antioxidants in atherosclerosis.
    Steinberg D
    Adv Exp Med Biol; 1995; 369():39-48. PubMed ID: 7598015
    [No Abstract]   [Full Text] [Related]  

  • 22. Oxidative hypothesis of atherogenesis.
    Klatt P; Esterbauer H
    J Cardiovasc Risk; 1996 Aug; 3(4):346-51. PubMed ID: 8946263
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Trimetazidine as indirect antioxidant.
    Tikhaze AK; Lankin VZ; Zharova EA; Kolycheva SV
    Bull Exp Biol Med; 2000 Oct; 130(10):951-3. PubMed ID: 11177290
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enzymatic efficiency of erythrocyte antioxidant barrier and lipid peroxidation in children from families with high risk of early atherosclerosis.
    Hapyn E; Czerwionka-Szaflarska M; Drewa G
    Med Sci Monit; 2000; 6(1):112-6. PubMed ID: 11208296
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antioxidants and atherosclerosis.
    Niki E
    Biochem Soc Trans; 2004 Feb; 32(Pt 1):156-9. PubMed ID: 14748738
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Antioxidant probucol is an efficient trap for lipid radicals in LDL in vitro and in vivo].
    Tikhaze AK; Lankin VZ; Konovalova GG; Shumaev KB; Kaminnyĭ AI; Kozachenko AI; Gurevich SM; Nagler LG; Zaĭtseva TM; Kukharchuk VV
    Biull Eksp Biol Med; 1999 Aug; 127(8):186-9. PubMed ID: 11188741
    [No Abstract]   [Full Text] [Related]  

  • 27. [Lipoproteins, antioxidants, and coronary cardiopathy].
    Guimarães AC
    Arq Bras Cardiol; 1995 Sep; 65(3):289-95. PubMed ID: 8579520
    [No Abstract]   [Full Text] [Related]  

  • 28. [Is there a relation between serum ferritin levels, oxidized LDL antibodies and vitamins and risk for coronary atherosclerosis].
    Soska V
    Vnitr Lek; 2004 Mar; 50(3):183-5. PubMed ID: 15125366
    [No Abstract]   [Full Text] [Related]  

  • 29. Lipid peroxidation and atherosclerosis: the importance of selected patient group analysis.
    Aviram M
    Isr Med Assoc J; 2003 Oct; 5(10):734-5. PubMed ID: 14719472
    [No Abstract]   [Full Text] [Related]  

  • 30. [Role of arterial ground substance in the pathogenesis of atherosclerosis].
    Miasnikov LA; Kasatkina LV
    Kardiologiia; 1972 Apr; 12(4):128-39. PubMed ID: 4339825
    [No Abstract]   [Full Text] [Related]  

  • 31. [Lipid peroxidation in the pathogenesis of atherosclerosis].
    Skoczyńska A; Andrzejak R
    Postepy Hig Med Dosw; 1997; 51(5):515-29. PubMed ID: 9489452
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bimonthly update: lipidology. Atherosclerosis.
    Abuja PM
    Curr Opin Lipidol; 1997 Dec; 8(6):U86-7. PubMed ID: 9440934
    [No Abstract]   [Full Text] [Related]  

  • 33. [Lipid peroxidation injury of endothelial cells and atherosclerosis].
    Zhou M; Chen Y
    Zhonghua Xin Xue Guan Bing Za Zhi; 1990 Aug; 18(4):248-50. PubMed ID: 2086188
    [No Abstract]   [Full Text] [Related]  

  • 34. Is the oxidative modification hypothesis relevant to human atherosclerosis? Do the antioxidant trials conducted to date refute the hypothesis?
    Steinberg D; Witztum JL
    Circulation; 2002 Apr; 105(17):2107-11. PubMed ID: 11980692
    [No Abstract]   [Full Text] [Related]  

  • 35. [Lipid peroxidation and antioxidative protection in patients with coronary heart disease].
    Belaia OL; Artamoshina NE; Kalmykova VI; Kuropteva ZV; Baĭder LM
    Klin Med (Mosk); 2009; 87(5):21-4. PubMed ID: 19565822
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationships between serum levels of autoantibodies against oxidized low density lipoproteins, lipid-soluble antioxidants and apolipoprotein B in patients with coronary heart disease.
    Bakalova RA; Hadzhimitova V; Ribarov S
    Gen Physiol Biophys; 2000 Mar; 19(1):103-13. PubMed ID: 10930142
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Markers of oxidative damage and antioxidant protection: assessment of LDL oxidation.
    Salonen JT
    Free Radic Res; 2000 Nov; 33 Suppl():S41-6. PubMed ID: 11191274
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Apolipoproteins, the lipid hypothesis and ischaemic heart disease.
    Avogaro P
    Przegl Lek; 1985; 42(8):602-6. PubMed ID: 4089215
    [No Abstract]   [Full Text] [Related]  

  • 39. The oxidative stress hypothesis of atherosclerosis: cause or product?
    Stehbens WE
    Med Hypotheses; 1999 Dec; 53(6):507-15. PubMed ID: 10687893
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Type 1 diabetes and ageing: does LDL oxidation mediate their associations with coronary heart disease?
    Valabhji J; Elkeles RS
    Eur Heart J; 2001 Nov; 22(22):2045-7. PubMed ID: 11686659
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.